Gemcitabine radiosensitizes multiple myeloma cells to low let, but not high let, irradiation

Radiotherapy and Oncology

Volumn 83, Issue 1, 2007, Pages 97-101

  Supiot, Stéphane ^a,b   Thillays, Francois ^a,b   Rio, Emmanuel ^b   Gouard, Sébastien ^a   Morgenstern, Alfred ^c   Bruchertseifer, Frank ^c   Mahé, Marc André ^a,b   Chatal, Jean François ^a,b   Davodeau, François ^a   Chérel, Michel ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b CENTRE RENÉ GAUDUCHEAU   (France)

^c JOINT RESEARCH CENTRE   (Italy)

Author keywords

Alpha particles; Antimetabolites; Homologous recombination; Multiple myeloma; Radioimmunotherapy

Indexed keywords

GEMCITABINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IRRADIATION; ISOTOPE LABELING; LINEAR ENERGY TRANSFER; MULTIPLE MYELOMA; PRIORITY JOURNAL; RADIOSENSITIZATION;

ALPHA PARTICLES; ANTIMETABOLITES, ANTINEOPLASTIC; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DEOXYCYTIDINE; GAMMA RAYS; HUMANS; LINEAR ENERGY TRANSFER; MULTIPLE MYELOMA; RADIATION DOSAGE; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS;

EID: 34047149756     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.02.005     Document Type: Article

References (28)

1. Baker C.H., Banzon J., Bollinger J.M., et al. 2′-Deoxy-2′-methylenecytidine and 2′-deoxy-2′,2′-difluorocytidine 5′-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase. J Med Chem 34 (1991) 1879-1884
2. Blakely E.A., Ngo F.Q.H., Curtis S.B., and Tobias C.A. Heavy-ion radiobiology: cellular studies. Adv Radiat Biol 11 (1984) 295-389
3. Brechbiel M.W., and Gansow O.A. Synthesis of C-Functionalized trans-cyclohexyldiethylnenetriaminepenta-acetic acid for labelling of monoclonal antibodies with the bismuth-212 alpha-particle emitter. J Chem Soc Perkin Trans 1 (1992) 1173-1178
4. Fertil B., Dertinger H., Courdi A., and Malaise E.P. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res 99 (1984) 73-84
5. Goodhead D.T. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol 65 (1994) 7-17
6. Heilmann J., Taucher-Scholz G., Haberer T., Scholz M., and Kraft G. Measurement of intracellular dna double-strand break induction and rejoining along the track of carbon and neon particle beams in water. Int J Radiat Oncol Biol Phys 34 (1996) 599-608
7. Heinemann V., Xu Y.Z., Chubb S., et al. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol Pharmacol 38 (1990) 567-572
8. Hoglund E., Blomquist E., Carlsson J., and Stenerlow B. DNA damage induced by radiation of different linear energy transfer: initial fragmentation. Int J Radiat Biol 76 (2000) 539-547
9. Huang P., Chubb S., Hertel L.W., Grindey G.B., and Plunkett W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 51 (1991) 6110-6117
10. Jenner T.J., deLara C.M., O'Neill P., and Stevens D.L. Induction and rejoining of DNA double-strand breaks in V79-4 mammalian cells following gamma- and alpha-irradiation. Int J Radiat Biol 64 (1993) 265-273
11. Latz D., Fleckenstein K., Eble M., Blatter J., Wannenmacher M., and Weber K.J. Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys 41 (1998) 875-882
12. Lawrence T.S., Blackstock A.W., and McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13 (2003) 13-21
13. Lawrence T.S., Chang E.Y., Hahn T.M., Hertel L.W., and Shewach D.S. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys 34 (1996) 867-872
14. Lawrence T.S., Chang E.Y., Hahn T.M., and Shewach D.S. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (Gemcitabine). Clin Cancer Res 3 (1997) 777-782
15. Lobrich M., Cooper P.K., and Rydberg B. Non-random distribution of DNA double-strand breaks induced by particle irradiation. Int J Radiat Biol 70 (1996) 493-503
16. Ostruszka L.J., and Shewach D.S. The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine. Cancer Res 60 (2000) 6080-6088
17. Ostruszka L.J., and Shewach D.S. The role of DNA synthesis inhibition in the cytotoxicity of 2′,2′-difluoro-2′-deoxycytidine. Cancer Chemother Pharmacol 52 (2003) 325-332
18. Pauwels B., Korst A.E., de Pooter C.M., et al. The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro. Eur J Cancer 39 (2003) 838-846
19. Pauwels B., Korst A.E., Lardon F., and Vermorken J.B. Combined modality therapy of gemcitabine and radiation. Oncologist 10 (2005) 34-51
20. Pawlik T.M., and Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 928-942
21. Robinson B.W., and Shewach D.S. Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breast carcinoma cell lines. Clin Cancer Res 7 (2001) 2581-2589
22. Schy W.E., Hertel L.W., Kroin J.S., Bloom L.B., Goodman M.F., and Richardson F.C. Effect of a template-located 2′,2′-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3′→5′exonuclease-) fragment. Cancer Res 53 (1993) 4582-4587
23. Shewach D.S., Hahn T.M., Chang E., Hertel L.W., and Lawrence T.S. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res 54 (1994) 3218-3223
24. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3 (2003) 155-168
25. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol (Baltimore, Md.: 1950), 1981. 126(4): p. 1614-9.
26. van Putten J.W.G., Groen H.J.M., Smid K., Peters G.J., and Kampinga H.H. End-joining deficiency and radiosensitization induced by gemcitabine. Cancer Res 61 (2001) 1585-1591
27. Wachters F.M., van Putten J.W., Maring J.G., Zdzienicka M.Z., Groen H.J., and Kampinga H.H. Selective targeting of homologous DNA recombination repair by gemcitabine. Int J Radiat Oncol Biol Phys 57 (2003) 553-562
28. Wijdenes J., Vooijs W.C., Clement C., et al. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 94 (1996) 323